Agenda On July 23, 2026, the Committee will discuss the following bulk drug substances being considered for inclusion on the 503A Bulks List: BPC-157-related bulk drug substances (BPC-157 (free base)/ BPC-157 acetate), KPV-related bulk drug substances (KPV (free base)/ KPV acetate), TB-500-related bulk drug substances (TB-500 (free base)/ TB-500 acetate), and MOTs-C-related bulk drug substances (MOTs-C (free base)/ MOTs-C acetate)
[2] Metabolic effects of the growth hormone fragment AOD9604 in obese rodents Ng FM, et al
Received: Accepted: Published: Version of record: DOI:
Pairs with this No reviews yet
At Perfect B in Doral, FL, we are currently evaluating this peptide internally before making it available to patients
This means several things for researchers: First, the safety database is smaller than for approved compounds